"10.1371_journal.pone.0061154","plos one","2013-04-12T00:00:00Z","Niaina Rakotosamimanana; T Mark Doherty; Lova H Andriamihantasoa; Vincent Richard; Brigitte Gicquel; Jean-Louis Soares; Alimuddin Zumla; Voahangy Rasolofo Razanamparany","Unité des Mycobactéries, Institut Pasteur de Madagascar, Antananarivo, Madagascar; Staten Serum Institut, Copenhagen, Denmark; Unité dépidémiologie, Institut Pasteur de Madagascar, Antananarivo, Madagascar; Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France; Division of Infection and Immunity, University College London, London, United Kingdom","Conceived and designed the experiments: TMD JLS BG AZ VRR. Performed the experiments: NR LHA. Analyzed the data: NR VR VRR TMD. Contributed reagents/materials/analysis tools: BG TMD AZ VRR. Wrote the paper: NR TMD AZ VRR. Obtained the VACSIS grant: AZ. Grant co-PI: TMD. Madagascar grant holder and coordinated the study: VRR.","One of the authors (TMD) is now employed by GlaxoSmithKline as an adviser on vaccination. The work described in this manuscript was completed prior to his current employment, and GlaxoSmithKline has had no input into the study design, execution, or analysis, or the writing of the manuscript. Prof. TMD holds no shares, patents or grants in GlaxoSmithKline or other companies involved in TB research or treatment, and therefore has no identified conflicts of interest. TMD is a PLOS ONE Editorial Board member. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Niaina Rakotosamimanana","NR",8,TRUE,5,2,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
